Published in J Med Genet on March 22, 2005
Panel-based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory. Clin Genet (2014) 2.33
Genetic testing and cancer risk management recommendations by physicians for at-risk relatives. Genet Med (2011) 2.08
Primary care physicians' knowledge of and experience with pharmacogenetic testing. Clin Genet (2012) 2.07
Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol (2014) 1.91
Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians. Cancer Epidemiol Biomarkers Prev (2008) 1.64
Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling. J Gen Intern Med (2011) 1.56
Genetic education for primary care providers: improving attitudes, knowledge, and confidence. Can Fam Physician (2009) 1.40
Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilization. J Gen Intern Med (2009) 1.14
Primary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics. Nicotine Tob Res (2008) 1.12
Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels. BMC Med Genet (2009) 1.10
Genetic data and electronic health records: a discussion of ethical, logistical and technological considerations. J Am Med Inform Assoc (2013) 1.03
Communication, encouragement, and cancer screening in families with and without mutations for hereditary nonpolyposis colorectal cancer: a pilot study. Genet Med (2009) 1.03
A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer. Genet Test Mol Biomarkers (2013) 1.03
Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys. Am J Prev Med (2014) 1.01
Professional perspectives about pharmacogenetic testing and managing ancillary findings. Genet Test Mol Biomarkers (2011) 1.01
Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting. Pharmacogenomics (2014) 0.96
Delivery of Internet-based cancer genetic counselling services to patients' homes: a feasibility study. J Telemed Telecare (2010) 0.96
Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia. Genet Med (2011) 0.96
Postal survey of physicians and laboratories: practices and perceptions of molecular oncology testing. BMC Health Serv Res (2009) 0.95
Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.95
Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. J Natl Cancer Inst (2014) 0.93
Patterns of cancer genetic testing: a randomized survey of Oregon clinicians. J Cancer Epidemiol (2012) 0.91
Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers. Breast Cancer Res Treat (2011) 0.90
Pre-test genetic counseling services for hereditary breast and ovarian cancer delivered by non-genetics professionals in the state of Florida. Clin Genet (2014) 0.88
Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing. Fam Cancer (2014) 0.88
A systematic review of factors that act as barriers to patient referral to genetic services. Eur J Hum Genet (2014) 0.88
Cancer risk assessment by rural and Appalachian family medicine physicians. J Rural Health (2009) 0.84
Sustained effects of online genetics education: a randomized controlled trial on oncogenetics. Eur J Hum Genet (2013) 0.84
Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic. J Genet Couns (2013) 0.83
BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance. Ann Oncol (2015) 0.82
Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers. Clin Genet (2013) 0.82
Reflex testing for Lynch syndrome: if we build it, will they come? Lessons learned from the uptake of clinical genetics services by individuals with newly diagnosed colorectal cancer (CRC). Fam Cancer (2014) 0.82
Do Breast Cancer Patients Tested in the Oncology Care Setting Share BRCA Mutation Results with Family Members and Health Care Providers? J Cancer Epidemiol (2012) 0.81
Survey on knowledge, attitudes, and training needs of Italian residents on genetic tests for hereditary breast and colorectal cancer. Biomed Res Int (2014) 0.80
A multidisciplinary clinic for individualizing management of patients at increased risk for breast and gynecologic cancer. Fam Cancer (2012) 0.80
Non-genetic health professionals' attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer. Fam Cancer (2016) 0.79
Improving referral for genetic risk assessment in ovarian cancer using an electronic medical record system. Int J Gynecol Cancer (2014) 0.78
Cancer genetic counselor information needs for risk communication: a qualitative evaluation of interview transcripts. J Pers Med (2013) 0.77
Are public health professionals prepared for public health genomics? A cross-sectional survey in Italy. BMC Health Serv Res (2014) 0.77
Accuracy of ovarian and colon cancer risk assessments by U.S. physicians. J Gen Intern Med (2014) 0.77
Physicians' current practices and opportunities for DNA banking of dying patients with cancer. J Oncol Pract (2011) 0.76
A model for patient-direct screening and referral for familial cancer risk. Fam Cancer (2016) 0.75
Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample. Med Decis Making (2015) 0.75
Public Health Approaches and Barriers to Educating Providers about Hereditary Breast and Ovarian Cancer Syndrome. Healthcare (Basel) (2016) 0.75
Insights into BRCA1/2 Genetic Counseling from Ethnically Diverse Latina Breast Cancer Survivors. J Genet Couns (2017) 0.75
Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing. Expert Rev Mol Diagn (2016) 0.75
Identification of the breast cancer susceptibility gene BRCA2. Nature (1996) 17.14
Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med (2002) 8.18
The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med (1997) 4.66
Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol (2004) 3.88
Persuasive communication and medical technology assessment. Arch Intern Med (1985) 2.41
Awareness of family health history as a risk factor for disease--United States, 2004. MMWR Morb Mortal Wkly Rep (2004) 2.28
A systems model of clinical preventive care: an analysis of factors influencing patient and physician. Health Educ Q (1992) 2.21
Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet (2004) 1.96
Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol (2002) 1.86
Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol (2002) 1.86
Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev (2003) 1.83
US physicians' attitudes toward genetic testing for cancer susceptibility. Am J Med Genet A (2003) 1.77
Genetics education for primary-care providers. Nat Rev Genet (2002) 1.73
Physicians' knowledge of genetics and genetic tests. Acad Med (1993) 1.62
Physician knowledge and attitudes towards molecular genetic (DNA) testing of their patients. Clin Genet (1998) 1.47
Use of cancer susceptibility testing among primary care physicians. Clin Genet (2003) 1.30
Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol (2000) 1.27
Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. MMWR Morb Mortal Wkly Rep (2004) 1.23
Do physicians tailor their recommendations for breast cancer risk reduction based on patient's risk? J Gen Intern Med (2004) 1.13
The gap between practice and genetics education of health professionals: HuGEM survey results. Genet Med (2001) 1.04
Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer. Fam Cancer (2003) 1.03
Hereditary nonpolyposis colorectal cancer: preventive management. Cancer Treat Rev (2003) 1.02
Screening adherence in BRCA1/2 families is associated with primary physicians' behavior. Am J Med Genet A (2004) 0.99
Colorado family physicians' knowledge of hereditary breast cancer and related practice. J Cancer Educ (2001) 0.98
Prevention and genetic testing for breast cancer: variations in medical decisions. Soc Sci Med (2004) 0.95
Gynecologists' training, knowledge, and experiences in genetics: a survey. Obstet Gynecol (2000) 0.94
Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location. Genet Med (2003) 0.92
Recognition and management of hereditary breast cancer syndromes. Oncologist (2004) 0.92
Effects of a cancer genetics education programme on clinician knowledge and practice. J Med Genet (2004) 0.90
The importance of paternal family history in hereditary breast cancer is underappreciated by health care professionals. Oncology (2003) 0.90
HNPCC: an uncommon but important diagnosis. Gastroenterology (2001) 0.87
Inherited cancer and the primary care physician. Barriers and strategies. Cancer (1999) 0.84
Guidelines for breast and ovarian cancer genetic counseling referral: adoption and implementation in HMOs. Genet Med (2003) 0.83
Translational research on hereditary colon, breast, and ovarian cancers. J Natl Cancer Inst Monogr (1995) 0.81
The Oncormed approach to genetic testing. Genet Test (1997) 0.80
French physicians' knowledge about hereditary breast/ovarian cancer: the need for continuing vocational training in genetics. Community Genet (1999) 0.80
A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell (1983) 20.32
Dopamine neuron agenesis in Nurr1-deficient mice. Science (1997) 5.40
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68
Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A (2002) 4.03
Transcriptional 'enhancers' from SV40 and polyoma virus show a cell type preference. Nucleic Acids Res (1982) 3.94
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol (1984) 3.21
Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med (1989) 3.03
Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science (1996) 2.83
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature (1995) 2.69
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med (1985) 2.54
The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst (1998) 2.53
Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst (1999) 2.49
Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA (2001) 2.45
Organ donation in three major American cities with large Latino and black populations. Transplantation (1988) 2.41
Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron (1990) 2.22
Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer (1980) 2.04
Solid tumors after chronic lymphocytic leukemia. Blood (2001) 2.01
Analysis of the transcriptional enhancer effect. Cold Spring Harb Symp Quant Biol (1983) 1.99
Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci U S A (1990) 1.94
Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for the regulation of BDNF and NGF mRNA. J Cell Biol (1992) 1.87
Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer (1999) 1.84
Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice. J Neurosci (2001) 1.81
US physicians' attitudes toward genetic testing for cancer susceptibility. Am J Med Genet A (2003) 1.77
Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J Neurosurg (1985) 1.75
Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA (1978) 1.74
The dynamics of a heroin addiction epidemic. Science (1973) 1.74
Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science (1979) 1.74
Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci U S A (1983) 1.72
Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res Mol Brain Res (1996) 1.70
Cost-effectiveness of strategies to enhance mammography use. Eff Clin Pract (2001) 1.65
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
Dental pulp cells produce neurotrophic factors, interact with trigeminal neurons in vitro, and rescue motoneurons after spinal cord injury. Dev Biol (2001) 1.61
Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system. Proc Natl Acad Sci U S A (1986) 1.56
Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord (1998) 1.55
Amyl nitrite may alter T lymphocytes in homosexual men. Lancet (1982) 1.54
Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81. J Natl Cancer Inst (1984) 1.54
Comparison of benefits provided by different hearing aid technologies. J Am Acad Audiol (2001) 1.53
Subsequent cancer in patients with chronic lymphocytic leukemia--a possible immunologic mechanism. J Natl Cancer Inst (1978) 1.53
Assessing mammographers' accuracy. A comparison of clinical and test performance. J Clin Epidemiol (2000) 1.51
High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med (1985) 1.51
Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. Exp Cell Res (1999) 1.51
Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid. J Neurosci (2001) 1.50
Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes Dev (2001) 1.50
Growth characteristics of adrenergic nerves in the adult rat. Fluorescence histochemical and 3H-noradrenaline uptake studies using tissue transplantations to the anterior chamber of the eye. Acta Physiol Scand Suppl (1970) 1.45
Alpha-bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression. J Neurosci (1993) 1.42
Comparison of hemodynamic, pulmonary, and renal effects of use of three types of fluids after major surgical procedures on the abdominal aorta. Crit Care Med (1979) 1.39
Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy. Am J Hum Genet (1986) 1.39
Nerve growth factors in the rat iris. Nature (1980) 1.39
Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits. Mol Cell Biol (1994) 1.38
Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci (1999) 1.38
Lingual deficits in BDNF and NT3 mutant mice leading to gustatory and somatosensory disturbances, respectively. Development (1997) 1.38
Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization. Exp Neurol (1990) 1.37
Natural history of intrahepatic canine islet cell autografts. J Clin Invest (1986) 1.37
Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience (2003) 1.36
Expression of the beta-nerve growth factor gene in hippocampal neurons. Science (1988) 1.35
Malignant melanoma in renal-transplant recipients. Lancet (1981) 1.33
Ontogenesis of peripheral adrenergic neurons in the rat: pre- and postnatal observations. Acta Physiol Scand (1970) 1.33
Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet (1982) 1.31
Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1. Mol Endocrinol (1996) 1.31
Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials. N Engl J Med (1982) 1.29
On the projections from the locus coeruleus noradrealine neurons: the cerebellar innervation. Brain Res (1971) 1.29
Safe at home? Domestic violence and other homicides among women in New Mexico. Ann Emerg Med (1996) 1.28
Expression of nerve growth factor receptor mRNA is developmentally regulated and increased after axotomy in rat spinal cord motoneurons. Neuron (1989) 1.28
A national survey of the home visiting practice and attitudes of family physicians and internists. Arch Intern Med (1992) 1.28
Effect of variations in operational definitions on performance estimates for screening mammography. Acad Radiol (2000) 1.27
Familial and sporadic Hodgkin's disease associated with occupational wood exposure. Lancet (1978) 1.26
Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson's disease. Neuroscience (2008) 1.26
Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats. Brain Res (1972) 1.26
Chlorhexidine-induced degeneration of adrenergic nerves. Acta Neuropathol (1984) 1.25
The ability of human Schwann cell grafts to promote regeneration in the transected nude rat spinal cord. Exp Neurol (1997) 1.25
Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc Natl Acad Sci U S A (1995) 1.24
Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial. Circulation (2004) 1.24
Variation in mammographic breast density by race. Ann Epidemiol (2001) 1.24
Radiogenic male breast cancer with in vitro sensitivity to ionizing radiation and bleomycin. Cancer Invest (1983) 1.24
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol (1989) 1.24
Melphalan may be a more potent leukemogen than cyclophosphamide. Ann Intern Med (1986) 1.23
Evidence against Ha-ras-1 involvement in sporadic and familial melanoma. Nature (1987) 1.21
Retinoid-X receptor signalling in the developing spinal cord. Nature (1998) 1.21
Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp Neurol (1993) 1.19
Health indicators and intimate partner violence among women who are members of a managed care organization. Prev Med (1999) 1.17
NURR1 mutations in cases of schizophrenia and manic-depressive disorder. Am J Med Genet (2000) 1.16
Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation. Ther Drug Monit (1999) 1.15
Brain-derived neurotrophic factor mRNA is expressed in the developing taste bud-bearing tongue papillae of rat. J Comp Neurol (1995) 1.15
Pigment analysis of chloroplast pigment-protein complexes in wheat. Plant Physiol (1983) 1.14
Orphan nuclear receptor Nurr1 is essential for Ret expression in midbrain dopamine neurons and in the brain stem. Mol Cell Neurosci (2001) 1.14
Encephalopathy and fatty degeneration of the viscera: a clinicopathologic analysis of 40 cases. Am J Clin Pathol (1971) 1.13
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet (2003) 1.13
Differential expression of brain-derived neurotrophic factor and neurotrophin 3 mRNA in lingual papillae and taste buds indicates roles in gustatory and somatosensory innervation. J Comp Neurol (1996) 1.13
Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol (1987) 1.13
Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU). N Engl J Med (1983) 1.12
Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet (1980) 1.12
Mycosis fungoides: epidemiologic observations. Cancer Treat Rep (1979) 1.11
Early outpatient preoperative anesthesia assessment: does it help to reduce operating room cancellations? Anesth Analg (1999) 1.11
MitoPark mice mirror the slow progression of key symptoms and L-DOPA response in Parkinson's disease. Genes Brain Behav (2009) 1.10
Impact of the Sahelian drought in Mauritania, West Africa. Lancet (1974) 1.10
Cancer mortality among printing plant workers. Environ Res (1979) 1.10
Electrophysiological and cytological studies of brain homografts in the anterior chamber of the eye: maturation of cerebellar cortex in oculo. Brain Res (1974) 1.09
Cellular and subcellular localization of protein I in the peripheral nervous system. Proc Natl Acad Sci U S A (1982) 1.09
Fluorescence-microscopical demonstration of a population of gastro-intestinal nerve fibres with a selective affinity for quinacrine. Cell Tissue Res (1976) 1.08